Cargando…
Surveillance in testicular cancer: who, when, what and how?
Surveillance as a management strategy in stage 1 testicular germ cell tumour (GCT) is increasing in popularity due to the recognition of the long-term side effects of treatment. Imaging, in particular computed tomography (CT), plays a central part in the surveillance protocols. There is a tendency t...
Autores principales: | Sohaib, S.A., Husband, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072090/ https://www.ncbi.nlm.nih.gov/pubmed/17964956 http://dx.doi.org/10.1102/1470-7330.2007.0023 |
Ejemplares similares
-
Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021) -
Aiming for the end of the COVID-19 pandemic: the what, how, who, where, and when
por: Soriano, Joan B., et al.
Publicado: (2023) -
What, When, and Who: Optimizing Recruitment to Pediatric Pulmonology
por: Chiel, Laura, et al.
Publicado: (2020) -
Redefining surveillance strategies: innovations in testicular cancer care
por: Chavarriaga, Julian, et al.
Publicado: (2023) -
News in the classification of WHO 2022 testicular tumours
por: Colecchia, Maurizio, et al.
Publicado: (2023)